Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:52 PM
Ignite Modification Date:
2025-12-24 @ 10:52 PM
NCT ID:
NCT00889369
Eligibility Criteria:
Inclusion Criteria:
* peri-/postmenopausal women, aged 40-60 year
* moderate to severe major depressive episode
Exclusion Criteria:
* DSM-IV Axis I diagnosis other than MDD
* contraindications to magnetic resonance imaging
* treatment-resistent
* previous failed treatment with duloxetine
* history of substance abuse or dependence in past year
* serious suicidal risk
* use of other psychotropic medications
* electroconvulsive therapy or transmagnetic stimulation in past year
* history of allergic reactions to duloxetine
* significant laboratory abnormalities at baseline
* severe hepatic impairment
* end stage renal disease and undergoing dialysis
* uncontrolled narrow-angle glaucoma
* uncontrolled or untreated hyper-/hypothyroidism, or abnormal thyroid stimulating hormone concentration
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
40 Years
Maximum Age:
60 Years
Study:
NCT00889369
Study Brief:
Protocol Section:
NCT00889369